Publicador de contenidos

Eliminación de la malaria

Epigenetic variation in malaria parasites II

Investigating new aspects of the mechanisms and biological functions of epigenetic variation in malaria parasites

Duración
01/01/2017-31/12/2019
Coordinador
Alfred Cortés
Financiadores
RETOS (MINECO, Spanish Government)

Many genes of the parasite responsible for the most severe forms of malaria, Plasmodium falciparum, are switched on in some individual parasites and switched off in others. The expression of these genes, termed clonally variant genes, is regulated at the epigenetic level. Importantly, clonally variant genes participate in key host-parasite interactions including antigenic variation, sexual conversion, nutrient acquisition or erythrocyte invasion.

In this project we explore the role of epigenetic variation and clonally variant gene expression in relevant P. falciparum biological pathways. We mainly focus on the clag gene family, involved in nutrient acquisition and resistance to toxic compounds, and pfap2-g, which is the master regulator of sexual conversion, a process necessary for malaria transmission. We also investigate how parasites adapt to heat-shock mimicking malaria cyclical fevers. We study both the chromatin-based mechanisms of epigenetic regulation and the function of these clonally variant genes. More generally, using these genes as models we gain insight into how parasites use epigenetic variation as an adaptive strategy to survive under different conditions of their human host.

Nuestro equipo

PI

ISGlobal Team

Otros proyectos

Ver proyectos pasados

MESA

La Alianza Científica para la Erradicación de la Malaria (MESA) tiene como objetivo avanzar en la ciencia de la erradicación de la malaria.

NHEPACHA

Nuevas Herramientas para el Diagnóstico y la Evaluación del Paciente con Enfermedad de Chagas

Estudio inmunológico de la vacuna RTS,S

Estudio de correlatos de protección frente a la malaria después de la vacunación con RTS,S/AS01E: Una evaluación inmunológica exhaustiva en el ensayo clínico de Fase III, doble ciego, aleatorizado, multicéntrico con un grupo control

Euroleish.net

Control of Leishmaniasis. From bench to bedside and community

GREPIMER

Grup de recerca en patología importada i malaties emergents i re-emergents

TESEO

Nuevos regímenes de quimioterapia y biomarcadores para la enfermedad de Chagas

ASINTMAL

Unravelling Disease Tolerance and Host Resistance in Afebrile 'P. falciparum' Infections: a Prospective Study in Mozambican Adults

ADAM

Administración masiva y focal de fármacos antimaláricos para avanzar hacia la eliminación de la malaria en Mozambique: acelerando la implementación de programas y políticas

MULTIPLY

MULTIple doses of IPTi Proposal: a Lifesaving high Yield intervention

Science4Pandemics

Citizens engagement digital platform for collective intelligence in pandemics

HIDDENVIVAX

Novel organ-on-a-chip technology to study extracellular vesicles-mediated cryptic infections in Plasmodium vivax malaria

MENA Migrant Health

Transforming data collection and surveillance to drive migrant health research, care and policy

SexMal

Social affairs and sex in P. falciparum: implications for malaria elimination

EpiGen

Building Scalable Pathogen Genomic Epidemiology in Ethiopia

SMART

Identifying Severe Malaria with a new Aptamer-based Rapid diagnostic Test

MalTransc

Transcriptional regulation of adaptation and developmental decisions in malaria parasites: from epigenetic variation to directed transcriptional responses

GenMoz

P. falciparum genomic intelligence in Mozambique

BOHEMIA

Broad One Health Endectocide-based Malaria Intervention in Africa